Otriduo cold dosing spray 15 ml

What is Otriduo cold and when is it used?

Otriduo cold contains a mild decongestant and an antihistamine. Otriduo cold brings rapid and lasting relief from swollen nasal mucosa (blocked nose) and runny nose.

Otriduo cold is suitable for the short-term symptomatic treatment of blocked nose and itching such as colds, sinusitis (inflammation of the sinuses), hay fever, allergic non-seasonal rhinitis (inflammation of the nasal mucosa, e.g. triggered by house dust, animal hair, mould).

Otriduo Cold can also be used before or after an operation and as a supportive medicine in the treatment of acute middle ear infections if prescribed by a doctor.

When should Otriduo Cold not be used?

Otriduo cold should not be used in the following cases:

• if you are hypersensitive to one of the active ingredients (dimetindene maleate, phenylephrine) or one of the excipients according to the composition,
• if you suffer from chronic rhinitis that has led to a thinning of the nasal mucosa,
• if you are currently taking monoamine oxidase inhibitors (MAO inhibitors, medicines for depression en) are taking or have taken within the last 14 days,
• if you suffer from glaucoma (i.e. an eye disease with increased intraocular pressure),
• after transnasal surgery (surgical interventions in the nose area where the epidermis has been exposed).

When should caution be exercised when using Otriduo cold?

Talk to your doctor before use if you have

• high blood pressure, cardiovascular disease,
• overactive thyroid gland,
• suffer from diabetes (diabetes) or
• epilepsy,
• difficulty urinating (e.g. prostatic hypertrophy),
• blood are taking pressure-lowering medicines (e.g. beta blockers), mood-enhancing medicines (MAO inhibitors, tri- or tetracyclic antidepressants) or anti-Parkinson medicines (see also «When should Otriduo cold not be used?»).

Otriduo cold should not be used for more than 3 days uninterrupted. If there is no improvement after 3 days or if the symptoms worsen, you should seek medical advice. Long-term or excessive use can cause chronic inflammation of the nasal mucosa (rhinitis medicamentosa).

Otriduo cold can cause sleep disorders, drowsiness and tremors in sensitive people.

Otriduo cold is not intended for use in the mouth or in the eyes.

The prescribed dose must not be exceeded, especially in small children and elderly people.

Otriduo cold Dosing spray is not recommended for children under 6 years of age.

Otriduo Schnupfen should be used in children from 6 to 12 years of age under adult supervision.

Information on the excipients

Benzalkonium chloride can cause irritation or swelling of the nasal mucosa, especially with prolonged use.

Inform your doctor, pharmacist or druggist or your doctor, pharmacist or druggist if you

• suffer from other illnesses,
• have allergies or
• use other medicines (including those you bought yourself!)!

Can Otriduo cold be used during pregnancy or while breastfeeding?

Systematic scientific research has never been conducted. Phenylephrine and dimetindene maleate may be excreted in breast milk. Otriduo SchnuTo be on the safe side, pf should not be used during pregnancy and breastfeeding.

How do you use Otriduo Schnupfen dosing spray?

Do not exceed the stated dosage and frequency of use.

The lowest effective dosage should always be used for the shortest possible duration of therapy.

Adults and children over 6 years of age (under adult supervision):

1-2 sprays into each nostril 3 to 4 times a day give.

Children under the age of 6

Otriduo nasal dosing spray is not recommended for children under the age of 6.

Use of the dosing spray

• Clean your nose thoroughly before use (e.g. blow your nose).
• Be careful not to get the spray mist in your eyes.
• Remove the protective cap. Before the very first use, press the pump 5 times to start the spraying process. The dosing spray is now ready for any further application. If the product has not been used for a long time, the pump must be operated 5 times again before use.
• Insert the spray head into one nostril, spray 1 time (press firmly) and inhale through your nose at the same time. Repeat the process for the other nostril.
• Wipe and dry the spray head before replacing the protective cap.

A bottle of Otriduo nasal dosing spray should only be used by one person to avoid the possible spread of infection.

Do not use continuously for more than 3 days. If there is no improvement after 3 days or if the symptoms worsen, you should seek medical advice.

Follow the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.

What side effects can Otriduo cold have?

The following side effects may occur when using Otriduo cold: In rare cases (affects 1 to 10 in 10,000 people treated), local and temporary burning or dryness of the nose and nosebleeds may occur.

If you notice any side effects, contact your doctor, pharmacist or druggist. This also applies in particular to side effects that are not listed in this leaflet.

What else should I be aware of?

Shelf life

The medicinal product may only be used up to the date marked «EXP» on the container.

Storage instructions

Keep out of the reach of children.

Otriduo cold dosing spray: Protect from light and store at 15-30°C.

Further information

Your doctor, pharmacist or druggist can provide you with further information or your doctor, pharmacist or druggist. These people have the detailed information for professionals.

What does Otriduo nasal dosing spray contain?

Active ingredients

1 ml Otriduo nasal dosing spray contains 0.25 mg dimetindene maleate and 2.5 mg phenylephrine.

1 spray (=0.14 ml) contains: 0.035 mg dimetindene maleate and 0.35 mg phenylephrine.

Excipients

Sorbitol, sodium monohydrogen phosphate, citro renic acid monohydrate, lavandin oil, benzalkonium chloride, purified water.

Authorization number

60125 (Swissmedic).

Where can you get the Otriduo Cold Dosing Spray? What packs are available?

In pharmacies and drugstores, without a doctor's prescription.

Otriduo nasal dosing spray (microdoseur): PaPack of 15 ml.

Authorization holder

GSK Consumer Healthcare Schweiz AG, Risch.

This package leaflet was last checked by the drug authority (Swissmedic) in January 2021.